MAIA Biotechnology Inc. (MAIA)
AMEX: MAIA
· Real-Time Price · USD
1.47
-0.04 (-2.65%)
At close: Sep 04, 2025, 10:25 AM
-2.65% (1D)
| Bid | 1.46 |
| Market Cap | 48.34M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -16.17M |
| EPS (ttm) | -0.54 |
| PE Ratio (ttm) | -2.71 |
| Forward PE | -2.16 |
| Analyst | n/a |
| Ask | 1.49 |
| Volume | 38,586 |
| Avg. Volume (20D) | 460,259 |
| Open | 1.50 |
| Previous Close | 1.51 |
| Day's Range | 1.47 - 1.50 |
| 52-Week Range | 1.40 - 3.74 |
| Beta | 0.03 |
About MAIA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MAIA
Website n/a
1 week ago
+7.14%
MAIA Biotechnology shares are trading higher after...
Unlock content with
Pro Subscription
1 month ago
+9.24%
MAIA Biotechnology shares are trading higher after the company announced it dosed its first patient in its Taiwan expansion stage of the THIO-101 Phase 2 trial.
2 months ago · https://www.marketscreener.com
MAIA Biotechnology, Inc. announced that it expects to receive $0.587904 million in funding from Prevail PartnersMAIA Biotechnology, Inc entered into a stock purchase agreement at maximum of 337,876 shares at a price $1.74 per share for gross proceeds $5,87,904.24 on June 26, 2025. The transaction included parti...
